Huntingtin localization in brains of normal and Huntington's disease patients

Annals of Neurology

Volumn 42, Issue 4, 1997, Pages 604-612

  Sapp, E ^b   Schwarz, C ^b   Chase, K ^b   Bhide, P G ^b   Young, A B ^b   Penney, J ^b   Vonsattel, J P ^b   Aronin, N ^b   DiFiglia, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; HUNTINGTIN; MUTANT PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADOLESCENT; AGED; ANTIBODIES; AXONS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CATHEPSIN D; CELL NUCLEUS; CEREBRAL CORTEX; CORPUS STRIATUM; CYTOPLASM; DENDRITES; HUMANS; HUNTINGTON DISEASE; IMMUNOENZYME TECHNIQUES; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PYRAMIDAL CELLS; TRINUCLEOTIDE REPEATS;

EID: 0030771894     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420411     Document Type: Article

References (45)

1. Folstein SE. Huntington's disease: a disorder of families. Baltimore: Johns Hopkins University Press, 1989:1-64
2. Byers RK, Gilles FH, Fung C. Huntington's disease in children. Neuropathological study of four cases. Neurology 1973;23:561-569
3. Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985;227:770-773
4. Cudkowicz M, Kowall NS. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 1990;27:200-204
5. De La Monte SM, Vonsattel J-P, Richardson EP Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-525
6. Myers RH, Vonsattel JP, Paskevich PA, et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991;50:729-742
7. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
8. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983
9. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-392
10. Stine OC, Pleasant N, Franz ML, et al. Correlations between the onset age of Huntington's disease and length of the trinucleotide repeat in IT15. Hum Mol Genet 1993;2:1547-1549
11. Aronin N, Chase K, Young C, et al. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron 1995;15:1193-1201
12. Ide K, Nukina H, Masuda N, et al. Abnormal gene product identified in Huntington's disease lymphocytes and brain. Biochem Biophys Res Commun 1995;209:1119-1125
13. Trottier Y, Lutz Y, Stevanin F, et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995;378:403-406
14. DiFiglia M, Sapp E, Chase K, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995;14:1075-1081
15. Gutekunst CA, Levey AI, Heilman DJ, et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci USA 1995;92:8710-8714
16. Sharp AH, Loev SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995;14:1065-1074
17. Sapp E, Schwarz C, Chase K, et al. Altered neuronal expression and intracellular trafficking of huntingtin in the Huntington's disease brain. Soc Neurosci Abstr 1996;22:226 (Abstract)
18. Sapp E, Ge P, Aizawa H, et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 1995;64:397-404
19. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:245-254
20. Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995;14:671-680
21. Bhide PJ, Day M, Sapp E, et al. Expression of normal and mutant huntingtin in the developing brain. J Neurosci 1996;16:5523-5535
22. Ferrante RJ, Kowall NW, Beal MF, et al. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987; 46:12-27
23. Ferrante RJ, Kowall NW, Beal MF, et al. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985;230:561-563
24. Li X-J, Li S-H, Sharp AH, et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995;378:398-402
25. Li X-J, Sharp AH, Li SH, et al. Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc Natl Acad Sci USA 1996;93:4839-4844
26. Landwehrmeyer GB, McNeil SM, Dure LS, et al. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 1995;37:218-230
27. Albin RL, Reiner A, Anderson K, et al. Preferential loss of striato-external pallidal and striato-nigral projection neurons in presymptomatic Huntington's disease. Ann Neurol 1992;31:425-430
28. Reiner A, Albin RL, Anderson KD, et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988;85:5733-5737
29. Richfield EK, Maguire-Zeiss KA, Cox C, et al. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann Neurol 1995;37:335-343
30. LaVail JH, LaVail MM. The retrograde intraaxonal transport of horseradish peroxidase in the chick visual system: a light and electron microscopic study. J Comp Neurol 1974;157:303-358
31. Felder S, Miller K, Moehren G, et al. Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 1990;61:623-634
32. Hollenbeck RJ. Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport. J Cell Biol 1993;121:305-315
33. Velier J, Schwarz C, Young C, et al. Wild-type and mutant huntingtin localize to the Golgi complex and to vesicles in the peripheral cytoplasm in fibroblasts of control and HD patients. Soc Neurosci Abstr 1996;22:226 (Abstract)
34. Nixon RA, Cataldo AM. The endosomal-lysosomal system of neurons: new roles. Trends Neurosci 1995;18:489-496
35. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1993;16:125-131
36. DiFiglia M. Excitotoxicity model of Huntington's disease. Trends Neurosci 1990;13:286-289
37. Coyle JT, Puttfarcken PP. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695
38. Whetsell WO Jr. Current concepts of excitotoxicity. J Neuropathol Exp Neurol 1996;55:1-13
39. Choi D. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369-379
40. Huang Q, Zhou D, Sapp E, et al. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Neuroscience 1995;65:397-407
41. Hori N, Carpenter DO. Functional and morphological changes induced by transient in vivo ischemia. Exp Neurol 1994;129:279-289
42. Matesic DF, Lin RCS. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 1994;63:1012-1020
43. Bindokas VP, Miller RJ. Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons. J Neurosci 1995;15:6999-7011
44. Hedreen JC, Peyser CE, Folstein SE, et al. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991;133:257-261
45. 3H]AMPA binding in layer VI of frontal cortex in Huntington's disease. Exp Neurol 1994;126:1-6